Akebia Therapeutics Inc (AKBA)
R&D Expense Growth
-5.05%
Quarterly · Period ending:
AKBA R&D Expense Growth
Latest reported-5.05%period ending
Latest reported-5.05%period ending
AKBA Quarterly R&D Growth (QoQ) (0.00% → -5.05%)
Latest values, visible window
High-resolution chart · PNG
AKBA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.0517% | |
| -44.4349% | |
| 82.1961% | |
| 32.8067% | |
| 12.9075% | |
| -17.2408% | |
| 38.8712% | |
| 10.9847% | |
| -21.4161% | |
| -1.3583% | |
| -25.994% | |
| -34.0001% | |
| 2.5958% | |
| -38.2961% | |
| 13.829% | |
| 7.6882% | |
| -40.6224% | |
| 48.3049% | |
| -26.9699% | |
| 8.7521% | |
| -8.3647% | |
| 8.0712% | |
| -19.8028% | |
| -11.2876% | |
| -34.9768% | |
| 1.0185% | |
| 7.9182% | |
| -13.0488% | |
| 4.0595% | |
| -5.4665% | |
| 23.3301% | |
| -1.784% | |
| 17.121% | |
| -10.2044% | |
| 16.4722% | |
| 34.1935% | |
| -27.1412% | |
| 79.5992% | |
| 7.0331% | |
| 1.1692% | |
| 52.592% | |
| 61.3765% | |
| -20.589% | |
| 119.8552% | |
| -4.3038% | |
| 6.1828% | |
| 6.3177% | |
| 20.3281% | |
| -10.28% | |
| 93.0022% | |
| -1.5247% | |
| 32.0832% | |
| 29.2553% | |
| 235.0207% | |
| 0% |